Hamburg Says Rhetoric Over FDA's Effect On Innovation Could Harm Regulatory Process

In a speech to the consumer group Public Citizen, FDA Commissioner Margaret Hamburg says the increasingly heated complaints that the agency is stifling medical product development could undermine public confidence in regulatory standards and approved products.